Subsequently, the occurrence of specific-mutations, such as RhoA G17V and IDH-2 R172K/S, observed exclusively in TFH-cells, lead to a second hit that modulates the differentiation and proliferation of clonal TFH-cells, orchestrating the development of AITL (32). The gene discussed is IDH2; the disease is angioimmunoblastic T-cell lymphoma.